CJC-1295 with DAC is a synthetic growth hormone–releasing hormone (GHRH) analog designed for prolonged activity due to its Drug Affinity Complex (DAC) modification. It is studied for its ability to stimulate sustained endogenous growth hormone release. In experimental studies, CJC-1295 with DAC has been investigated for its effects on metabolism, tissue regeneration, and anabolic signaling. It is commonly considered in preclinical models exploring long-term growth hormone regulation, body composition, and regenerative pathways. Studied for sustained stimulation of endogenous growth hormone secretion Investigated for effects on metabolism and energy homeostasis Explored for influence on tissue repair and anabolic pathways Considered in preclinical models of growth, recovery, and endocrine research
